Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2024 Earnings Call Transcript July 31, 2024
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $0.61, expectations were $0.57.
Operator: Hello, and welcome to the Teva Pharmaceuticals Industries Limited Q2 2024 Earnings Call. My name is Alex, and I’ll be coordinating the call today. [Operator Instructions] I’ll now hand it over to your host, Ran Meir, SVP, Head of Investor Relations. Please go ahead.
Ran...
